| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 3,004,000 | 2,516,000 | 2,699,000 | 2,458,000 | | Cost of Revenue | 1,499,000 | 1,147,000 | 1,182,000 | 1,110,000 | | | Gross Profit | 1,505,000 | 1,369,000 | 1,517,000 | 1,348,000 | | | Operating Expenses | | Research Development | 118,000 | 130,000 | 98,000 | 92,000 | | Selling General and Administrative | 1,133,000 | 734,000 | 680,000 | 722,000 | | Non Recurring | (103,000) | 64,000 | 212,000 | 3,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 357,000 | 441,000 | 527,000 | 531,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 128,000 | 15,000 | 10,000 | 17,000 | | Earnings Before Interest And Taxes | 485,000 | 456,000 | 537,000 | 548,000 | | Interest Expense | 44,000 | 43,000 | 43,000 | 45,000 | | Income Before Tax | 441,000 | 413,000 | 494,000 | 503,000 | | Income Tax Expense | 357,000 | 140,000 | 322,000 | 130,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 84,000 | 273,000 | 172,000 | 373,000 | | | Non-recurring Events | | Discontinued Operations | (28,000) | 33,000 | (13,000) | 13,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 56,000 | 306,000 | 159,000 | 386,000 | | Preferred Stock And Other Adjustments |
-
| (25,000) | 25,000 |
-
| | | Net Income Applicable To Common Shares | $56,000 | $281,000 | $184,000 | $386,000 |
|
0.29% Nasdaq 0.00%
Income Statement
